Modulation of Cytokine Release and Gene Expression by the Immunosuppressive Domain of gp41 of HIV-1

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Denner, Joachim ^a   Eschricht, Magdalena ^a   Lauck, Michael ^a   Semaan, Marwan ^a   Schlaermann, Philipp ^a   Ryu, Hyunmi ^a   Akyüz, Levent ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; FICOLIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN GP 41; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

AMINO ACID SEQUENCE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84873836730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055199     Document Type: Article

References (61)

1. Wilen CB, Tilton JC, Doms RW, (2012) Molecular mechanisms of HIV entry. Adv Exp Med Biol 726: 223-42.
2. Oostendorp RA, Meijer CJ, Scheper RJ, (1993) Immunosuppression by retroviral-envelope-related proteins, and their role in non-retroviral human disease. Crit Rev Oncol Hematol 14: 189-206.
3. Denner J, (1998) Immunosuppression by retroviruses: implications for xenotransplantation. Ann NY Acad Sci 862: 75-86.
4. Mangeney M, de Parseval N, Thomas G, Heidmann T, (2001) The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J Gen Virol 82: 2515-2518.
5. Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, et al. (2007) Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA 104: 20534-20539.
6. Cianciolo G, Copeland T, Oroszlan S, Snyderman R, (1985) Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230: 453-455.
7. Ruegg C, Monell C, Strand M, (1989) Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J Virol 63: 3257-3260.
8. Ruegg C, Monell C, Strand M, (1989) Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. J Virol 63: 3250-3256.
9. Denner J, Norley S, Kurth R, (1994) The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS 8: 1063-1072.
10. Denner J, Persin C, Vogel T, Haustein D, Norley S, et al. (1996) The immunosuppressive peptide of HIV-1 inhibits T and B lymphocyte stimulation. J Acquir Immune Defic Syndr Hum Retrovirol 12: 442-450.
11. Fausther-Bovendo H, Vieillard V, Sagan S, Bismuth G, Debré P, (2010) HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway. PLoS Pathog. 1 6: e1000975.
12. Haraguchi S, Good R, Day N, (1995) Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 16: 595-603.
13. Gottlieb RA, Kleinermann ES, O'Brian CA, Tsujimoto S, Cianciolo GJ, et al. (1990) Inhibition of protein kinase C by a peptide conjugate homologous to a domain of retroviral protein p15E. J Immunol 145: 2566-2570.
14. Kadota J, Cianciolo GJ, Snyderman R, (1991) A synthetic peptide homologous to retroviral transmembrane envelope proteins depresses proteinkinase C mediated lymphocyte proliferation and directly inactivated protein kinase C: A potential mechanism for immunosuppression. Microbiol Immunol 35: 443-459.
15. Ruegg CL, Strand M, (1990) Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. J Immunol 144: 3928-3935.
16. Ruegg CL, Strand M, (1991) A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx. Cell Immunol 137: 1-13.
17. Koutsonikolis A, Haraguchi S, Brigino EN, Owens UE, Good RA, et al. (1997) HIV-1 recombinant gp41 induces IL-10 expression and production in peripheral blood monocytes but not in T-lymphocytes. Immunol Lett 55: 109-113.
18. Speth C, Joebstl B, Barcova M, Dierich MP, (2000) HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones. AIDS 14: 629-636.
19. Barcova M, Speth C, Kacani L, Uberall F, Stoiber H, et al. (1999) Involvement of adenylate cyclase and p70(S6)-kinase activation in IL-10 up-regulation in human monocytes by gp41 envelope protein of human immunodeficiency virus type 1. Pflugers Arch 437: 538-546.
20. Denner J, (2000) How does HIV induce AIDS? The virus protein hypothesis. J Hum Virol 3: 81-82.
21. Morozov V, Morozov A, Semaan M, Denner J, (2012) Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1. Retrovirology 9: 67.
22. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
23. Woessner F, Nagase H (2000) Matrix metalloproteinases and TIMPs. (New York: Oxford University Press).
24. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, et al. (2003) A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170: 3812-3818.
25. Bouchon A, Dietrich J, Colonna M, (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164: 4991-4995.
26. Endo Y, Matsushita M, Fujita T, (2007) Role of ficolin in innate immunity and its molecular basis. Immunobiology 212: 371-379.
27. Egesten A, Eliasson M, Johansson HM, Olin AI, Morgelin M, et al. (2007) The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195: 684-963.
28. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, et al. (2007) Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 167: 148-154.
29. Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, et al. (2005) Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33: 792-796.
30. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, et al. (2001) Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum 44: 176-179.
31. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest Vol 102: 1369-1376.
32. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, et al. (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 95: 9465-9470.
33. Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, et al. (1990) Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 144: 480-484.
34. Honda M, Kitamura K, Mizutani Y, Oishi M, Arai M, et al. (1990) Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J Immunol. 145(12): 4059-4064.
35. Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, et al. (2006) Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses 22: 757-762.
36. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, et al. (2006) Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 193(5): 703-712.
37. Webster NL, Crowe SM, (2006) Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J Leukoc Biol 80: 1052-1066.
38. Ghorpade A, Persidskaia R, Suryadevara R, Che M, Liu XJ, et al. (2001) Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia. J Virol 75: 6572-6583.
39. Pardo A, Selman M, (2005) MMP-1: the elder of the family. Int J Biochem Cell Biol 37: 283-288.
40. Gómez-Piña V, Martínez E, Fernández-Ruíz I, Del Fresno C, Soares-Schanoski A, et al. (2012) Role of MMPs in orchestrating inflammatory response in human monocytes via a TREM-1-PI3K-NF-κB pathway. J Leukoc Biol 91: 933-945.
41. Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, Del Fresno C, García F, et al. (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179(6): 4065-4073.
42. Jinquan T, Møller B, Storgaard M, Mukaida N, Bonde J, et al. (1997) Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects. J Immunol 158: 475-484.
43. Deshmane SL, Kremlev S, Amini S, Sawaya BE, (2009) Monocyte chemoattractant protein-1 (MCP-1): An Overview. J Interferon Cytokine Res 29: 313-326.
44. Lane BR, Strieter RM, Coffey MJ, Markovitz DM, (2001) Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. J Virol 75: 5812-5822.
45. Honoré C, Rørvig S, Munthe-Fog L, Hummelshøj T, Madsen HO, et al. (2008) The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Mol Immunol 45: 2782-2789.
46. Dworkin BM, (1994) Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact 91: 181-186.
47. Allavena C, Dousset B, May T, Dubois F, Canton P, et al. (1995) Relationship of trace element, immunological markers, and HIV1 infection progression. Biol Trace Elem Res 47: 133-8.
48. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, et al. (1997) High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 15: 370-374.
49. Stone CA, Kawai K, Kupka R, Fawzi WW, (2010) Role of selenium in HIV infection. Nutr Rev 68: 671-681.
50. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, et al. (2007) Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 167: 148-154.
51. Takeshita S, Breen EC, Ivashchenko M, Nishanian PG, Kishimoto T, et al. (1995) Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) in the THP-1 human monocytic cell line. Cell Immunol. 165(2): 234-242.
52. Haraguchi S, Good RA, Day-Good NK, (2008) A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways. Immunol Res 41: 46-55.
53. Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, et al. (2001) Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat Med 7: 725-731.
54. Chen YH, Böck G, Vornhagen R, Steindl F, Katinger H, et al. (1993) The human monocyte cell line U937 binds HIV-1 gp41 by proteins of 37, 45, 49, 62 and 92 kDa. Immunol Lett 37: 41-45.
55. Henderson LA, Qureshi MN, (1993) A peptide inhibitor of human immunodeficiency virus infection binds to novel cell surface polypeptides. J Biol Chem 268: 16291-16297.
56. Denner J, Vogel T, Norley S, Hoffmann A, Kurth R, (1995) The immunosuppressive (ISU-) peptide of HIV-1: Binding proteins on lymphocytes detected by different methods. J Cancer Res Clin Oncol 121 (S1): 35.
57. Nicholas J, (2005) Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 25: 373-383.
58. Slobedman B, Barry PA, Spencer JV, Avdic S, Abendroth A, (2009) Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol 83: 9618-9629.
59. Marie JC, Kehren J, Trescol-Biémont MC, Evlashev A, Valentin H, et al. (2001) Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity 14: 69-79.
60. Moss WJ, Ota MO, Griffin DE, (2004) Measles: immune suppression and immune responses. Int. J. Biochem. Cell Biol 36: 1380-1385.
61. Hartman AL, Ling L, Nichol ST, Hibberd ML, (2008) Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J Virol 82: 5348-5358.